ASPIRE BIOPHARMA HLDGS INC *W EXP 02/14/203

ASPIRE BIOPHARMA HLDGS INC *W EXP 02/14/203 is a security (CUSIP 738920115) tracked across SEC portfolio filings. 36 institutional managers reported $152K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $1K via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 36 managers by value.

ManagerLocationValueShares
Saba Capital Management, L.P.NEW YORK, NY$18K983,603
ADAGE CAPITAL PARTNERS GP, L.L.C.Boston, MA$17K1,050,000
Linden Advisors LPNew York, NY$17K899,999
CLEAR STREET LLCNEW YORK, NY$15K331,064
ARISTEIA CAPITAL LLCGREENWICH, CT$12K681,516
Sculptor Capital LPNew York, NY$9K500,000
TORONTO DOMINION BANKToronto, Ontario, A6$9K516,345
Clear Street Group Inc.NEW YORK, NY$5K330,664
Clear Street Derivatives LLCNEW YORK, NY$5K106,000
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$5K
HIGHBRIDGE CAPITAL MANAGEMENT LLCNEW YORK, NY$4K273,000
Context Capital Management, LLCLAJOLLA, CA$4K175,000
Antara Capital LPNEW YORK, NY$3K207,693
D. E. Shaw & Co., Inc.New York, NY$3K199,999
WOLVERINE ASSET MANAGEMENT LLCCHICAGO, IL$3K197,144

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Saba Capital Income & Opportunities FundSaba Capital Income & Opportunities Fund$1K0.03%

More